Cleared Traditional

ClearPointer Optical Navigation Wand (K233155) - FDA 510(k) Clearance

Class II Neurology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K233155 · ClearPoint Neuro, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2024
Decision
107d
Days
Class 2
Risk

K233155 is an FDA 510(k) clearance for the ClearPointer Optical Navigation Wand. Classified as Neurological Stereotaxic Instrument (product code HAW), Class II - Special Controls.

Submitted by ClearPoint Neuro, Inc. (Solana Beach, US). The FDA issued a Cleared decision on January 12, 2024 after a review of 107 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.4560 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all ClearPoint Neuro, Inc. devices

Submission Details

510(k) Number K233155 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 27, 2023
Decision Date January 12, 2024
Days to Decision 107 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
41d faster than avg
Panel avg: 148d · This submission: 107d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code HAW Neurological Stereotaxic Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.4560
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - HAW Neurological Stereotaxic Instrument

All 156
Devices cleared under the same product code (HAW) and FDA review panel - the closest regulatory comparables to K233155.
Bone Anchor (NGS-BA-01)
K233703 · ClearPoint Neuro, Inc. · Apr 2024
SmartFrame OR
K233141 · ClearPoint Neuro, Inc. · Jan 2024
ClearPoint Bone Screw Fiducials
K233144 · ClearPoint Neuro, Inc. · Jan 2024
Zeta Cranial Navigation System (ZNS131-US)
K233903 · Zeta Surgical, Inc. · Jan 2024
ClearPoint System (Software Version 2.2)
K233243 · ClearPoint Neuro, Inc. · Nov 2023
StealthStation Cranial Software, v3.1.5 (9735585)
K231976 · Medtronic Navigation, Inc. · Oct 2023